The case for & against
Bull & Bear analysis
Bullish
Mpac Group plc (MPAC) is a UK-based company focused on providing automation solutions for packaging and manufacturing processes, primarily servicing the pharmaceutical, healthcare, and consumer goods industries. It is considered an emerging player within the broader industrial automation sector, capitalizing on the increasing demand for efficiency and innovation in supply chain operations. The company recently made significant moves to optimize its operations by selling non-core assets, thereby aiming to strengthen its financial position.
Bull says
- ↑Order book £98.8m vs £90.0m in Dec 2025 reflects solid demand rebound
- ↑Short and long-term moving averages emit strong buy signals
- ↑Lambert sale raised £16m to cut debt and bolster liquidity
- ↑DBAY Advisors at 10.11% and Griffiths at 6.29% show rising investor confidence
- ↑H1 2026 results on Sep 15 could catalyze share price if recovery sustains
- ↑High earnings yield with strong profitability and ROE underpin value
Bear says
- ↓June 2026 profit warning highlights risks to revenue momentum
- ↓Net loss and negative operating cash flow undermine stability
- ↓Leverage ratio climbing increases refinancing and liquidity pressure
- ↓RSI and stochastic overbought readings warn of short-term pullback
- ↓Negative P/E and no dividend limit investor appeal
- ↓Neutral analyst consensus and high short interest signal skepticism